Season 2 (2021-2030)

Cardiovascular - Phase2 (1)

Modality Indication Targets Stage Company Project No. Detail
1 Phase II clinical development of DPP-4 inhibitor (Evogliptin), a new drug for medical treatment of Aortic Stenosis
Small Molecules Aortic Stenosis DPP-4 Phase 2 REDNVIA HN21C1047
BACK